ATTECS

ATTECS (Antibody-Targeted Triggered Electrically Conductive Scaffold) represents an innovative approach in the field of biomedical engineering, particularly in targeted cancer therapy. This technology combines the specificity of antibodies, which can precisely target cancer cells, with the conductivity of electrically active scaffolds. These scaffolds are designed to selectively conduct electrical stimulation to areas identified by the antibodies, thus targeting the cancer cells directly. The primary objective of ATTECS is to enhance the effectiveness of treatments by delivering localized electrical signals that can induce cancer cell death or improve drug delivery, minimizing damage to surrounding healthy tissues. This method exemplifies a novel therapeutic strategy that merges biological targeting with electrical stimulation for precise medical interventions.